Suppr超能文献

食物蛋白诱导性肠病综合征对牛奶的患病率和自然病程:一项大规模、前瞻性的基于人群的研究。

The prevalence and natural course of food protein-induced enterocolitis syndrome to cow's milk: a large-scale, prospective population-based study.

机构信息

Allergy and Immunology Institute, Assaf Harofeh Medical Center, Zerifin, Israel.

出版信息

J Allergy Clin Immunol. 2011 Mar;127(3):647-53.e1-3. doi: 10.1016/j.jaci.2010.12.1105.

Abstract

BACKGROUND

The prevalence and natural history for food protein-induced enterocolitis syndrome (FPIES) have not been determined.

OBJECTIVE

We sought to determine the prevalence, clinical manifestations, and rate of recovery for FPIES in a large-scale, population-based prospective study.

METHODS

In a prospective study the feeding history of 13,019 infants was obtained. Infants with probable adverse reactions to cow's milk protein (CMP) were clinically examined, skin prick tested, and challenged orally. Diagnostic criteria for CMP-induced FPIES included age less than 9 months, delayed recurrent vomiting (usually with nausea), and lethargy after exposure to CMP in the absence of other IgE-mediated symptoms, such as rash, urticaria, and respiratory symptoms. In addition, a positive challenge response to milk resulted in the above-mentioned gastrointestinal symptoms, removal of milk from the diet resulted in the resolution of those symptoms, or both.

RESULTS

Ninety-eight percent of the cohort participated in the study. The cumulative incidence for FPIES was 0.34% (44/13,019 patients). The most common symptoms were recurrent vomiting (100%), lethargy (77%) diarrhea (25%), pallor (14%), and bloody diarrhea (4.5%). All patients had FPIES within the first 6 months of life. By the age of 3 years, 90% of the patients had recovered. We did not detect any concomitant reaction to soy. Eight patients with FPIES had IgE-mediated cow's milk allergy (IgE-CMA).

CONCLUSIONS

The prevalence of FPIES is significant, and its clinical presentation is distinct from that of IgE-CMA. Most patients with FPIES recover, although a proportion might convert to IgE-CMA. The likelihood for a cross-reactivity to soy in this population was less than previously estimated.

摘要

背景

食物蛋白诱导的肠病综合征(FPIES)的流行率和自然病史尚不清楚。

目的

我们旨在通过一项大规模、基于人群的前瞻性研究来确定 FPIES 的流行率、临床表现和恢复率。

方法

在一项前瞻性研究中,我们获得了 13019 名婴儿的喂养史。对疑似对牛奶蛋白(CMP)有不良反应的婴儿进行临床检查、皮肤点刺试验和口服挑战。CMP 诱导的 FPIES 的诊断标准包括年龄小于 9 个月、在接触 CMP 后出现延迟性复发性呕吐(通常伴有恶心)和嗜睡,且无其他 IgE 介导的症状,如皮疹、荨麻疹和呼吸道症状。此外,阳性牛奶挑战反应导致上述胃肠道症状、饮食中去除牛奶导致这些症状缓解,或两者兼而有之。

结果

该队列中 98%的婴儿参与了研究。FPIES 的累积发病率为 0.34%(44/13019 例患者)。最常见的症状是复发性呕吐(100%)、嗜睡(77%)、腹泻(25%)、面色苍白(14%)和血性腹泻(4.5%)。所有患者均在生命的前 6 个月内出现 FPIES。到 3 岁时,90%的患者已康复。我们未发现 FPIES 与大豆有任何伴随反应。8 名 FPIES 患者有 IgE 介导的牛奶过敏(IgE-CMA)。

结论

FPIES 的患病率很高,其临床表现与 IgE-CMA 不同。大多数 FPIES 患者可康复,尽管部分患者可能会转为 IgE-CMA。该人群对大豆发生交叉反应的可能性低于之前的估计。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验